Terms: = Breast cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3
121255 results:
1. ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2).
Ghosal N; Tapadar P; Biswas D; Pal R
Mol Biol Rep; 2024 May; 51(1):671. PubMed ID: 38787503
[TBL] [Abstract] [Full Text] [Related]
2. Modulation of heat shock protein expression and cytokine levels in MCF-7 cells through photodynamic therapy.
Dos Santos MIB; Godoi BH; Da Silva NS; Oliveira LD; de Paula Ramos L; Cintra RC; Pacheco-Soares C
Lasers Med Sci; 2024 May; 39(1):135. PubMed ID: 38787412
[TBL] [Abstract] [Full Text] [Related]
3. breast Glandular and Ductal Volume Changes during the Menstrual Cycle: A Study in 48 breasts Using Ultralow-Frequency Transmitted Ultrasound Tomography/Volography.
Wiskin J; Klock J; Love S
Tomography; 2024 May; 10(5):789-805. PubMed ID: 38787020
[TBL] [Abstract] [Full Text] [Related]
4. PI 3-Kinase and the Histone Methyl-Transferase KMT2D Collaborate to Induce Arp2/3-Dependent Migration of Mammary Epithelial Cells.
Rysenkova KD; Gaboriaud J; Fokin AI; Toubiana R; Bense A; Mirdass C; Jin M; Ho MCN; Glading E; Vacher S; Courtois L; Bièche I; Gautreau AM
Cells; 2024 May; 13(10):. PubMed ID: 38786098
[TBL] [Abstract] [Full Text] [Related]
5. Hypermethylation of the Gene Body in
Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
[TBL] [Abstract] [Full Text] [Related]
6. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
Longo CJ; Maity T; Fitch MI; Young JT
Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
[TBL] [Abstract] [Full Text] [Related]
7. Sonographic Evaluation of Nigerian Women with Mammographic Focal Asymmetric Density.
Itanyi DU; Ibrahim H; Ka'alu WO
West Afr J Med; 2024 Mar; 41(3):233-237. PubMed ID: 38785292
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
Chen L; Yan X; Luo T; Tian T; He P; Zhong X
Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya.
Elmaihub ES; Alhudiri I; Ramadan AM; Eljilani M; Elzagheid A; Elfagi F; Hassen E
Libyan J Med; 2024 Dec; 19(1):2356906. PubMed ID: 38785139
[TBL] [Abstract] [Full Text] [Related]
10. Investigation of calcium variations in single cells and the impact of Yoda1 on osteocytes by ICP-OES.
Guo X; Lin CY; Alavi S; You L; Mostaghimi J
Anal Chim Acta; 2023 Nov; 1281():341906. PubMed ID: 38783744
[TBL] [Abstract] [Full Text] [Related]
11. Systematic literature review of real-world evidence for treatments in HR+/HER2- second-line LABC/mBC after first-line treatment with CDK4/6i.
Lambert V; Kane S; Howidi B; Nguyen BN; Chandiwana D; Wu Y; Edwards M; Samjoo IA
BMC Cancer; 2024 May; 24(1):631. PubMed ID: 38783218
[TBL] [Abstract] [Full Text] [Related]
12. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
13. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
14. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
15. International Survey of Psychosocial Care for cancer Survivors in Low-/Middle- and High-Income Countries: Current Practices, Barriers, and Facilitators to Care.
Signorelli C; Høeg BL; Asuzu C; Centeno I; Estapé T; Fisher P; Lam W; Levkovich I; Manne S; Miles A; Mullen L; Nekhlyudov L; Sade C; Shaw J; Singleton A; Travado L; Tsuchiya M; Lemmen J; Li J; Jefford M;
JCO Glob Oncol; 2024 May; 10():e2300418. PubMed ID: 38781550
[TBL] [Abstract] [Full Text] [Related]
16. Anthracycline-induced arrhythmias in breast cancer therapy: A meta-analysis of single-arm trials.
Ran T; Chen J; She Q; Mu Y; Zhang M; Mao M; Zuo Z; Li J
PLoS One; 2024; 19(5):e0303208. PubMed ID: 38781221
[TBL] [Abstract] [Full Text] [Related]
17. cancer Treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
18. The diagnostic value of multimodal imaging based on MR combined with ultrasound in benign and malignant breast diseases.
Bai D; Zhou N; Liu X; Liang Y; Lu X; Wang J; Liang L; Wang Z
Clin Exp Med; 2024 May; 24(1):110. PubMed ID: 38780895
[TBL] [Abstract] [Full Text] [Related]
19. Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study.
Carson EK; Dhillon HM; Vardy JL; Brown C; Nunes-Zlotkowski KF; Della-Fiorentina S; Khan S; Parsonson A; Roncoloato F; Pearson A; Barnes T; Kiely BE
Support Care Cancer; 2024 May; 32(6):375. PubMed ID: 38780707
[TBL] [Abstract] [Full Text] [Related]
20. Mechanistic evaluation of myristicin on apoptosis and cell cycle regulation in breast cancer cells.
Sufina Nazar S; Ayyappan JP
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23740. PubMed ID: 38779996
[TBL] [Abstract] [Full Text] [Related]
[Next]